Rhythm Pharmaceuticals (RYTM) Revenue (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Revenue of $60.1 million for Q1 2026, up 83.81% year-over-year from $32.7 million in Q1 2025, and up 4.99% quarter-over-quarter from $57.3 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Revenue (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Revenue for 6 consecutive years, with $60.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 83.81% year-over-year to $60.1 million; the TTM figure through Mar 2026 stood at $217.2 million (up 58.67% YoY), while the FY2025 annual figure was $189.8 million, up 45.83% from the prior year.
- Revenue rose to $60.1 million in Q1 2026 per RYTM's latest filing, from $57.3 million in the prior quarter.
- Across five years, Revenue topped out at $60.1 million in Q1 2026 and bottomed at -$8.0 million in Q4 2022.
- Historically, Revenue has averaged $27.3 million across 5 years, with a median of $26.0 million in 2024.
- On a YoY basis, Revenue climbed as much as 4180.0% in 2022 and fell as far as 542.93% in 2022.
- Rhythm Pharmaceuticals' Revenue stood at -$8.0 million in 2022, then soared by 401.12% to $24.2 million in 2023, then soared by 72.61% to $41.8 million in 2024, then surged by 36.87% to $57.3 million in 2025, then advanced by 4.99% to $60.1 million in 2026.
- Business Quant data shows RYTM's Revenue at $60.1 million in Q1 2026, $57.3 million in Q4 2025, and $51.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 71.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.26 Mn |
| Mar 31, 2026 | 60.11 Mn |
| Dec 31, 2025 | 57.25 Mn |
| Sep 30, 2025 | 51.30 Mn |
| Jun 30, 2025 | 48.50 Mn |
| Mar 31, 2025 | 32.70 Mn |
| Dec 31, 2024 | 41.83 Mn |
| Sep 30, 2024 | 33.25 Mn |
| Jun 30, 2024 | 29.08 Mn |
| Mar 31, 2024 | 25.97 Mn |
| Dec 31, 2023 | 24.23 Mn |
| Sep 30, 2023 | 22.50 Mn |
| Jun 30, 2023 | 19.22 Mn |
| Mar 31, 2023 | 11.47 Mn |
| Dec 31, 2022 | -8.05 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 9.07 Mn |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 1.03 Mn |